Metformin Pill

ApprovedSmall molecule

FFudan University

Metformin Pill is one of 82 small molecule programs targeting Cognitive impairment. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cognitive ImpairmentActive, not recruiting

Polycystic Ovary SyndromeActive, not recruiting

Cognitive ImpairmentApproved

Active, not recruiting

Polycystic Ovary SyndromePreclinical

Active, not recruiting

Competition

Competitive Landscape

279 competitors in Cognitive Impairment

#DrugCompanyPhaseTrials

Actos

Takeda

Phase 3

3 2

Farxiga

AstraZeneca

Phase 3

1 3

Provigil

NNuvo Research GmbH

Phase 3

1 4

Xarelto

WWim Janssens

Phase 3

1 5

Aquasol E

NNational Eye Institute (NEI)

Phase 3

1 6

Viagra

VViatris Specialty LLC

Phase 3

1 7

Donepezil Hydrochloride

Eisai

Phase 3

3 8

Statins

Sanofi

Phase 3

1 9

Galantamine Hydrobromide

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3

4 10

Karxt

Bristol-Myers Squibb

Phase 3

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Metformin1 trial

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

Recruiting·KKaohsiung Medical University Chung-Ho Memorial Hospital·Phase 2·NCT06826092·110 enrolled

Cognitive impairment1 trial

Vildagliptin in Older Adults With Diabetes and Mild Cognitive Impairment

Completed·UUniversity of Catania·Phase 4·NCT03819127·60 enrolled

Obese1 trial

Treating Obese PCOS Patients With LSG vs. Met

Unknown status·SShanghai 10th People's Hospital·Phase 4·NCT04508634·90 enrolled

Polycystic Ovary Syndrome1 trial

Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety

Unknown status·FFudan University·N/A·NCT04984070·100 enrolled

Hypertensive1 trial

Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

Completed·MMTI University·Phase 4·NCT03253562·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Metformin Pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Metformin Pill compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Metformin Pill. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Fudan University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: FFudan University

Metformin Pill

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Metformin1 trial

Cognitive impairment1 trial

Obese1 trial

Polycystic Ovary Syndrome1 trial

Hypertensive1 trial

References

Drug Info

Quick Facts

Related News